Meeting
2018 Gastrointestinal Cancers Symposium
Impact of molecular tumor board on late-stage gastrointestinal malignancies at a tertiary center.
Authors
Timothy Lewis Cannon
Inova Schar Cancer Institute, Fairfax, VA
Timothy Lewis Cannon , Jo-Ellen Murphy , Jennifer Carter , Donald L. Trump , Sheryl Krevsky Elkin , Anam Asif , Laura Knopp , John Milburn Jessup
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 483)
DOI
10.1200/JCO.2018.36.4_suppl.483
Abstract #
483
Poster Bd #
N7
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
First Author: Katherine E Poruk
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes.
First Author: Lilly Gu
Poster
2018 ASCO Annual Meeting
Impact of cholangiocarcinoma (CC) molecular heterogeneity on outcome during first-line chemotherapy and access to targeted therapies in early clinical trials (CT).
First Author: Helena Verdaguer
Poster
2024 ASCO Annual Meeting
On the right TRACK: Providing comprehensive genomic profiling (CGP) and molecular tumor board (MTB) for patients (pts) with rare cancers.
First Author: Jim Palma